The expressions of LC3-II, Atg-5 and Beclin-1 in the monocytes of the patients peripheral blood are changed prominently after treatment with CRRT, so they are expected to be regarded as new prognostic indicators for AKI patients. The gene discussed is BECN1; the disease is acute kidney injury.